Suppr超能文献

可乐定对发作性睡病的影响。

Effects of clonidine in narcolepsy.

作者信息

Salín-Pascual R, de la Fuente J R, Fernández-Guardiola A

出版信息

J Clin Psychiatry. 1985 Dec;46(12):528-31.

PMID:4066618
Abstract

The antihypertensive drug clonidine was given in an open trial to two treatment-resistant (psychostimulants and tricyclic antidepressants) narcoleptic patients. When given acutely, clonidine suppressed REM sleep. However, patients became tolerant after repeated doses but did not lose the drug's beneficial clinical effects. This suggests that REM suppression may not be necessary for improvement in narcolepsy. Assessments of both clinical and polysomnographic variables before and after the trial indicate that clonidine may have a place in the treatment of some patients with narcolepsy.

摘要

在一项开放性试验中,给两名难治性(对精神兴奋剂和三环类抗抑郁药耐药)发作性睡病患者使用了抗高血压药物可乐定。急性给药时,可乐定可抑制快速眼动睡眠(REM睡眠)。然而,患者在重复给药后产生了耐受性,但并未失去该药的有益临床效果。这表明,发作性睡病病情改善可能并不需要抑制REM睡眠。试验前后对临床和多导睡眠图变量的评估表明,可乐定在某些发作性睡病患者的治疗中可能占有一席之地。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验